Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
2 Am J Epidemiol
2 Antimicrob Agents Chemother
6 Clin Infect Dis
2 HIV Med
4 J Acquir Immune Defic Syndr
1 J Clin Invest
4 J Infect Dis
1 Lancet
1 Nat Rev Immunol
1 Neurol Clin Pract
2 Pediatrics
5 PLoS One
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. WOMACK JA, Murphy TE, Leo-Summers L, Kidwai-Khan F, et al
    Performance of a modified fracture risk assessment tool (FRAX) for fragility fracture prediction among older veterans living with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003566.
    PubMed         Abstract available

  2. CHONGXING Z, Yuanchun L, Yan H, Dabin L, et al
    Evaluation of the Diagnostic Efficacy of EC-Test for Latent Tuberculosis Infection in Ambulatory People Living with HIV.
    AIDS. 2023 Apr 20. doi: 10.1097/QAD.0000000000003573.
    PubMed         Abstract available

  3. MARTYN-DICKENS C, Ojewale O, Sly-Moore E, Dompreh A, et al
    Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003576.
    PubMed         Abstract available

  4. SADA YH, da Costa WL Jr, Kramer JR, Chiao EY, et al
    Survival outcomes in Veterans with hepatocellular carcinoma, with and without HIV infection.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003568.
    PubMed         Abstract available

  5. ZHANG Z, Duri K, Duisters KLW, Schoeman JC, et al
    Altered methionine-sulfone levels are associated with impaired growth in HEU-children.
    AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003574.
    PubMed         Abstract available

  6. REDDON H, Fairbairn N, Grant C, Milloy MJ, et al
    Experiencing homelessness and progression through the HIV cascade of care among people who use drugs.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003570.
    PubMed         Abstract available

  7. RUBIN LH, Du Y, Sweeney SE, O'Toole R, et al
    Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003572.
    PubMed         Abstract available

  8. MARAGH-BASS AC, Stoner M, Castellanos-Usigli A, Agarwal H, et al
    New PrEP options need different counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities (YSGM) of color.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003563.

  9. LI MJ, Chau B, Garland WH, Oksuzyan S, et al
    Racial, gender, and psychosocial disparities in viral suppression trends among people receiving coordinated HIV care in Los Angeles County.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003578.
    PubMed         Abstract available

  10. RIVERA AS, Rusie LK, Feinstein MJ, Siddique J, et al
    Intersectionality-informed analysis of durable viral suppression disparities in people with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003565.
    PubMed         Abstract available

  11. TEBAS P, Lynn K, Azzoni L, Cocchella G, et al
    Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons.
    AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003575.
    PubMed         Abstract available

  12. REQUENA MB, Grabar S, Lanoy E, Pialoux G, et al
    Mortality in HCV-cured versus HCV-uninfected people with HIV: a matched analysis in the ANRS CO4 FHDH cohort.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003569.
    PubMed         Abstract available

  13. GRIFFIN DW, Pai Mangalore R, Hoy JF, Mcmahon JH, et al
    Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003579.
    PubMed         Abstract available

  14. FREDERIX K, Schwitters A, Chung G, Mccracken S, et al
    The state of the pediatric HIV epidemic in Lesotho: results from a population-based survey.
    AIDS. 2023 Apr 19. doi: 10.1097/QAD.0000000000003581.
    PubMed         Abstract available

    AIDS Res Hum Retroviruses

  15. PEREZ BARRAGAN E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al
    Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2022.0130.
    PubMed         Abstract available

  16. PILKINGTON V, Quinn K, Campbell LJ, Payne L, et al
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2023.0014.
    PubMed         Abstract available

    Am J Epidemiol

  17. SEWAK A, Lodi S, Li X, Shu D, et al
    Causal effects of stochastic PrEP interventions on HIV incidence among men who have sex with men.
    Am J Epidemiol. 2023 Apr 19:kwad097. doi: 10.1093.
    PubMed         Abstract available

  18. SACK DE, Shepherd BE, Audet CM, De Schacht C, et al
    Inverse Probability Weights for Quasi-Continuous Ordinal Exposures with a Binary Outcome: Method Comparison and Case Study.
    Am J Epidemiol. 2023 Apr 14:kwad085. doi: 10.1093.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  19. XIAO MA, Cleyle J, Yoo S, Forrest M, et al
    The G118R plus R263K Combination of Integrase Mutations Associated with Dolutegravir-Based Treatment Failure Reduces HIV-1 Replicative Capacity and Integration.
    Antimicrob Agents Chemother. 2023 Apr 18:e0138622. doi: 10.1128/aac.01386.
    PubMed         Abstract available

  20. HONG H, Aslam-Mir U, Kajubi R, Wallender E, et al
    Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.
    Antimicrob Agents Chemother. 2023 Mar 14:e0142722. doi: 10.1128/aac.01427.
    PubMed         Abstract available

    Clin Infect Dis

  21. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.

  22. HAZRA A, Cherabie JN
    Is Mpox a Sexually Transmitted Infection? Why Narrowing the Scope of This Disease May Be Harmful.
    Clin Infect Dis. 2023;76:1504-1507.
    PubMed         Abstract available

  23. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    PubMed         Abstract available

  24. LEVISON J, McKinney J, Duque A, Hawkins J, et al
    Breastfeeding among people with HIV in North America: a multisite study.
    Clin Infect Dis. 2023 Apr 20:ciad235. doi: 10.1093.
    PubMed         Abstract available

  25. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    PubMed         Abstract available

  26. VERDECIA JL, Vootukuri SR, Sands ML, Isache CL, et al
    A Case of Necrotizing Finger Lesions in a Patient With AIDS.
    Clin Infect Dis. 2023;76:1513-1515.

    HIV Med

  27. COUKAN F, Murray KK, Papageorgiou V, Lound A, et al
    Barriers and facilitators to HIV Pre-Exposure Prophylaxis (PrEP) in Specialist Sexual Health Services in the United Kingdom: A systematic review using the PrEP Care Continuum.
    HIV Med. 2023 Apr 19. doi: 10.1111/hiv.13492.
    PubMed         Abstract available

  28. GILLES C, Konopnicki D, Rozenberg S
    The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
    HIV Med. 2023 Apr 16. doi: 10.1111/hiv.13490.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  29. OMOLLO V, Asewe M, Mogere P, Maina G, et al
    The fidelity of a pharmacy-based oral HIV pre-exposure prophylaxis delivery model in Kenya.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003208.
    PubMed         Abstract available

  30. GANDHI AR, Hyle EP, Scott JA, Lee JS, et al
    The clinical impact and cost-effectiveness of clinic-based cognitive behavioral therapy for people with HIV, depression, and virologic failure in South Africa.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003205.
    PubMed         Abstract available

  31. LEW C, Fairley CK, Tran J, Phillips TR, et al
    High risk sexual activities and condom use patterns during group sex among men who have sex with men in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2023 Apr 19. doi: 10.1097/QAI.0000000000003211.
    PubMed         Abstract available

  32. LESIAPETO M, Shults J, Mmunyane M, Matshaba M, et al
    Stunted Growth is Associated with Dyslipidemia in Young Adults with Perinatal HIV Infection.
    J Acquir Immune Defic Syndr. 2023 Apr 17. doi: 10.1097/QAI.0000000000003209.
    PubMed         Abstract available

    J Clin Invest

  33. PIERCE CA, Loh LN, Steach HR, Cheshenko N, et al
    HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal.
    J Clin Invest. 2023 Apr 20:e164317. doi: 10.1172/JCI164317.
    PubMed         Abstract available

    J Infect Dis

  34. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
    Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
    J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
    PubMed         Abstract available

  35. ROBINSON JA, Niu M, Fox HS, Burdo TH, et al
    Antiretroviral therapy ameliorates SIV-associated myocarditis by dampening interferon signaling and pathogen response in the heart.
    J Infect Dis. 2023 Apr 19:jiad105. doi: 10.1093.
    PubMed         Abstract available

  36. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.

  37. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed         Abstract available


  38. HARRIS E
    World on Path to Eliminate AIDS as a Global Threat by 2030.
    JAMA. 2023;329:1248.


  39. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.

    Nat Rev Immunol

    Antiviral neutralizing antibodies: from in vitro to in vivo activity.
    Nat Rev Immunol. 2023 Apr 17:1-15. doi: 10.1038/s41577-023-00858.
    PubMed         Abstract available

    Neurol Clin Pract

  41. KWON PM, Lawrence S, Figueroa A, Robinson-Papp J, et al
    Autonomic Neuropathy as a Predictor of Morbidity and Mortality in People Living With HIV: A Retrospective, Longitudinal Cohort Study.
    Neurol Clin Pract. 2023;13:e200141.
    PubMed         Abstract available


  42. LAMPE MA, Nesheim SR, Oladapo KL, Ewing AC, et al
    Achieving Elimination of Perinatal HIV in the United States.
    Pediatrics. 2023 Apr 18:e2022059604. doi: 10.1542/peds.2022-059604.
    PubMed         Abstract available

  43. CHAKHTOURA N, Kapogiannis BG
    The Road to Zero Perinatal HIV Transmission in the United States.
    Pediatrics. 2023 Apr 18:e2022060209. doi: 10.1542/peds.2022-060209.

    PLoS One

  44. PEPPER K
    "If I don't take my treatment, I will die and who will take care of my child?": An investigation into an inclusive community-led approach to addressing the barriers to HIV treatment adherence by postpartum women living with HIV.
    PLoS One. 2023;18:e0271294.
    PubMed         Abstract available

  45. BAASSI M, Moussaoui M, Soufi H, Rajkhowa S, et al
    Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations.
    PLoS One. 2023;18:e0284539.
    PubMed         Abstract available

  46. MOYO I, Mavhandu-Mudzusi AH, Lipeleke F, Sibindi M, et al
    Access to HIV prevention, treatment, and care services during COVID-19 by men who have sex with men in Zimbabwe, An interpretive phenomenological analysis study.
    PLoS One. 2023;18:e0281799.
    PubMed         Abstract available

  47. AUSTIN-KEILLER A, Park M, Yang S, Mayo NE, et al
    "Alone, there is nobody": A qualitative study of the lived experience of loneliness in older men living with HIV.
    PLoS One. 2023;18:e0277399.
    PubMed         Abstract available

  48. AWAN A, Shakik S, Banack HR, Fisman DN, et al
    Hepatitis B and C in individuals with a history of antipsychotic medication use: A population-based evaluation.
    PLoS One. 2023;18:e0284323.
    PubMed         Abstract available


  49. ACCHIONI C, Acchioni M, Mancini F, Amendola A, et al
    A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation.
    Virology. 2023;583:1-13.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.